pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Jul 13·1 min read
save

Ohio launches $30M Life Science Training Center to boost biomanufacturing workforce

Jul 13, 2026·read at Fierce Biotech ↗Positive

Ohio’s JobsOhio agency and the Ohio Life Sciences Association announced a public-private training center backed by up to $30 million. The center is intended to create a statewide pipeline of operators and technicians for pharmaceutical manufacturing and biotechnology.

The program will partner with universities, community colleges and technical schools across all 88 Ohio counties, offering a standardized curriculum, certifications and a single entry point for employers and job seekers.

By addressing the workforce bottleneck, the initiative aims to make Ohio a more attractive location for biomanufacturing investment and support the full life-science value chain from research to distribution.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Building a workforce engine for biomanufacturing”

read at Fierce Biotech ↗
2,154 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN3Boundless Bio, Inc.HIKMASarepta Therapeutics, Inc.The Medicines CoUltragenyx Pharmaceutical Inc.
drugs
STERILE WATER
topics
OphthalmologyRare Disease

related stories

  • Jul 20How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 5d agoFDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Developmentfda press
  • 6d agoAnalysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earningsBioSpace
  • Sep 22GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potentialFierce Biotech